A Study to Investigate the Safety and Efficacy of GSK4532990 Compared With Placebo in Adult Participants Aged 18 to 70 Years With Alcohol-related Liver Disease (NCT06613698)
A Dose-Finding, Double-Blind, Placebo-Controlled Phase 2 Study to Evaluate the Efficacy and Safety of GSK4532990 for Steatohepatitis in Adults With Alcohol-related Liver Disease (ALD)
🩺 Plain-English Summary (8th-Grade Level)
The goal of this study is to assess the safety and efficacy of GSK4532990 in participants with alcohol-related liver disease.
Who can join: Review the eligibility criteria below.
Location: GSK Investigational Site — Chandler, Arizona
Age range: 18 Years to 70 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (140 Sites)
Showing the first 25 of 140 sites.
- GSK Investigational Site — Chandler, Arizona
- GSK Investigational Site — Phoenix, Arizona
- GSK Investigational Site — Tucson, Arizona
- GSK Investigational Site — Tucson, Arizona
- GSK Investigational Site — Coronado, California
- GSK Investigational Site — Lancaster, California
- GSK Investigational Site — Los Angeles, California
- GSK Investigational Site — Los Angeles, California
- GSK Investigational Site — Pasadena, California
- GSK Investigational Site — Sacramento, California
- GSK Investigational Site — Brandon, Florida
- GSK Investigational Site — Miami, Florida
- GSK Investigational Site — Miami Lakes, Florida
- GSK Investigational Site — Atlanta, Georgia
- GSK Investigational Site — Indianapolis, Indiana
- GSK Investigational Site — Topeka, Kansas
- GSK Investigational Site — Marrero, Louisiana
- GSK Investigational Site — Detroit, Michigan
- GSK Investigational Site — Las Vegas, Nevada
- GSK Investigational Site — New York, New York
- GSK Investigational Site — Chapel Hill, North Carolina
- GSK Investigational Site — Cleveland, Ohio
- GSK Investigational Site — Philadelphia, Pennsylvania
- GSK Investigational Site — Hermitage, Tennessee
- GSK Investigational Site — Arlington, Texas
📞 Contact the Study Coordinator
Phone: (877) 379-3718
Email: GSKClinicalSupportHD@gsk.com
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
Explore by condition: All Liver Diseases, Alcoholic clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.